We're trying out a new idea on the blog - the Mayo Clinic Research News Roundup. These columns will reprise research news releases from the past month, and link readers to those articles, as well as related resources.
Thank you for your continued support of Mayo Clinic Research!
July 1-15, 2017
July 14, Mayo Clinic and nference launched a startup company for drug development that will be powered by clinical expertise and artificial intelligence (AI). The company, named Qrativ(pronounced cure-a-tiv) will combine nference’s AI-driven knowledge synthesis platform with Mayo Clinic’s medical expertise and clinical data. Qrativ seeks to discover and develop treatments for diseases with unmet medical need. This effort is being boosted by an $8.3 million Series A financing supported by Matrix Capital Management, Matrix Partners and Mayo Clinic. Qrativ’s initial focus will be on rare diseases and highly targeted patient populations.
More than 4 in 5 opioid prescriptions given after surgery over a recent two-year period at Mayo Clinic exceeded guidelines now in the works, the clinic’s researchers have found. The research, published July 13 in the Annals of Surgery, also highlights a significant difference in opioid prescribing among Mayo Clinic’s Arizona, Florida and Rochester campuses, and within specific surgical procedures. The team of physicians and scientists expect their results will improve care for Mayo Clinic patients and help shape national policy and health care guidelines.
In a new study published in Prosthetics and Orthotics International, Mayo Clinic researchers describe the direct medical costs of falls in adults with a transfemoral amputation. In this type of amputation, the leg is amputated above the knee. This work “provides a comparison for policymakers when evaluating the value of more expensive … technologies,” say the authors.
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia – high blood sugar, or hypoglycemia – low blood sugar), says new research published in the Journal of General Internal Medicine.
Mayo Clinic is pleased to announce the launch of Mayo Clinic Proceedings: Innovations, Quality & Outcomes. An open-access, online medical research journal, Mayo Clinic Proceedings: Innovations, Quality & Outcomes is dedicated to “building upon innovations in research, advancing the quality of medical and surgical care, and promoting optimal patient outcomes.”
People with the movement disorder Parkinson’s disease have a much higher risk of the skin cancer melanoma, and vice versa, a Mayo Clinic study finds. While further research is needed into the connection, physicians treating one disease should be vigilant for signs of the other and counsel those patients about risk, the authors say. The findings are published in Mayo Clinic Proceedings.
Find research feature stories, videos and news on Discovery's Edge, Mayo Clinic's online research magazine.
Mayo Clinic Radio's 1-minute and in-depth discussions of research and practical patient information can be found online or via your local radio station.
Much of our content is available in Spanish as well.